This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LaBombardi, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LaBombardi, V. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2002, p. 2238-2239, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2238-2239.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Comparison of the ESP and BACTEC Systems for Testing Susceptibilities of Mycobacterium tuberculosis Complex Isolates to Pyrazinamide

Vincent J. LaBombardi*

Department of Laboratories, St. Vincent's Hospital Manhattan, New York, and Department of Pathology, New York Medical College, Valhalla, New York

Received 10 January 2002/ Returned for modification 20 February 2002/ Accepted 15 March 2002

Fifty isolates of Mycobacterium tuberculosis complex were tested for susceptibility to pyrazinamide (PZA) by the ESP (Trek Diagnostic Systems, Westlake, Ohio) and BACTEC (BD Biosciences, Sparks, Md.) test systems. Initial results showed concordance for 48 of the isolates. On retest, the two discordant isolates were resolved in favor of the ESP system. The ESP Myco susceptibility test system generates rapid, reliable PZA test results.

* Mailing address: Saint Vincent Catholic Medical Centers, St. Vincent's Hospital Manhattan, 153 W. 11th St., New York, NY 10011. Phone: (212) 604-8415. Fax: (212) 604-8426. E-mail: VLaBombard{at}saintvincentsnyc.org.

Journal of Clinical Microbiology, June 2002, p. 2238-2239, Vol. 40, No. 6
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.6.2238-2239.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rieder, R. J., Zhao, Z., Zavizion, B. (2009). New Approach for Drug Susceptibility Testing: Monitoring the Stress Response of Mycobacteria. Antimicrob. Agents Chemother. 53: 4598-4603 [Abstract] [Full Text]  
  • Singh, P., Wesley, C., Jadaun, G. P. S., Malonia, S. K., Das, R., Upadhyay, P., Faujdar, J., Sharma, P., Gupta, P., Mishra, A. K., Singh, K., Chauhan, D. S., Sharma, V. D., Gupta, U. D., Venkatesan, K., Katoch, V. M. (2007). Comparative Evaluation of Lowenstein-Jensen Proportion Method, BacT/ALERT 3D System, and Enzymatic Pyrazinamidase Assay for Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 45: 76-80 [Abstract] [Full Text]  
  • Piersimoni, C., Olivieri, A., Benacchio, L., Scarparo, C. (2006). Current Perspectives on Drug Susceptibility Testing of Mycobacterium tuberculosis Complex: the Automated Nonradiometric Systems. J. Clin. Microbiol. 44: 20-28 [Full Text]  
  • Takii, T., Hamasaki, S., Hirano, K., Abe, C., Onozaki, K. (2005). Simple Fibroblast-Based Assay To Test the Pyrazinamide Susceptibility of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49: 804-807 [Abstract] [Full Text]  
  • Bemer, P., Bodmer, T., Munzinger, J., Perrin, M., Vincent, V., Drugeon, H. (2004). Multicenter Evaluation of the MB/BACT System for Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 42: 1030-1034 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»